Thursday, June 23, 2016

BRIEF-Immunovaccine awarded subcontract to evaluate depovax for development of malaria vaccine targets

* Awarded a subcontract by leidos to evaluate

immunovaccine's depovax(tm) platform for development of peptide

based malaria vaccine targets

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more

No comments:

Post a Comment